Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: A meta-analysis

Human Genetics

Volumn 118, Issue 2, 2005, Pages 225-234

  Nath, Swapan K ^a,b   Harley, John B ^a,b   Lee, Young Ho ^a,c  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

^c Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR; INTERLEUKIN 10;

ALLELE; ARTICLE; ASIAN; CAUCASIAN; CONFIDENCE INTERVAL; ETHNOLOGY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MEDLINE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ALLELES; FEMALE; GENE FREQUENCY; HUMANS; INTERLEUKIN-10; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; META-ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, COMPLEMENT 3B;

EID: 27944511120     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-005-0044-6     Document Type: Article

References (57)

1. Alarcon-Riquelme ME, Lindqvist AK, Jonasson I, Johanneson B, Sandino S, Alcocer-Varela J, Granados J, Kristjansdottir H, Grondal G, Svenungsson E, Lundberg I, Steinsson K, Klareskog L, Sturfelt G, Truedsson L, Alarcon-Segovia D, Gyllensten UB (1999) Genetic analysis of the contribution of IL10 to systemic lupus erythematosus. J Rheumatol 26:2148-2152 10529131
2. Chong WP, Ip WK, Wong WH, Lau CS, Chan TM, Lau YL (2004) Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus. Genes Immun 5:484-492 15295621
3. Cohen JH, Caudwell V, Levi-Strauss M, Bourgeois P, Kazatchkine MD (1989) Genetic analysis of CR1 expression on erythrocytes of patients with systemic lupus erythematosus. Arthritis Rheum 32:393-397 2565113
4. Cornillet P, Gredy P, Pennaforte JL, Meyer O, Kazatchkine MD, Cohen JH (1992) Patients with systemic lupus erythematosus. Clin Exp Immunol 89:22-25 1352746
5. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P (1999) Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 42(6):1101-1108 10.1002/ 1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y
6. Crawley E, Woo P, Isenberg DA (1999) Single nucleotide polymorphic haplotypes of the interleukin-10 5' flanking region are not associated with renal disease or serology in Caucasian patients with systemic lupus erythematosus. Arthritis Rheum 42:2017-2018 10513824
7. D'Alfonso S, Giordano M, Mellai M, Lanceni M, Barizzone N, Marchini M, Scorza R, Danieli MG, Cappelli M, Rovere P, Sabbadini MG, Momigliano-Richiardi P (2002) Association tests with systemic lupus erythematosus (SLE) of IL10 markers indicate a direct involvement of a CA repeat in the 5′ regulatory region. Genes Immun 3:454-463 12486603
8. D'Alfonso S, Rampi M, Bocchio D, Colombo G, Scorza-Smeraldi R, Momigliano-Richardi P (2000) Systemic lupus erythematosus candidate genes in the Italian population: Evidence for a significant association with interleukin-10. Arthritis Rheum 43:120-128 10.1002/ 1529-0131(200001)43:1<120::AID-ANR15>3.0.CO;2-3
9. Davey SG, Egger M (1997) Meta-analyses of randomised controlled trials. Lancet 350:1182 9343537
10. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188 10.1016/0197-2456(86)90046-2
11. Dijstelbloem HM, Hepkema BG, Kallenberg CG, van der Linden MW, Keijsers V, Huizinga TW, Jansen MD, van de Winkel JG (2002) The R-H polymorphism of FCgamma receptor IIa as a risk factor for systemic lupus erythematosus is independent of single-nucleotide polymorphisms in the interleukin-10 gene promoter. Arthritis Rheum 46:1125-1126 10.1002/ art.518
12. Dykman TR, Cole JL, Iida K, Atkinson JP (1983) Polymorphism of human erythrocyte C3b/C4b receptor. Proc Natl Acad Sci USA 80:1698-1702 6572933
13. Dykman TR, Hatch JA, Aqua MS, Atkinson JP (1985) Polymorphism of the C3b/ C4b receptor (CR1): Characterization of a fourth allele. J Immunol 134:1787-1789 3155774
14. Dykman TR, Hatch JA, Atkinson JP (1984) Polymorphism of the human C3b/ C4b receptor. Identification of a third allele and analysis of receptor phenotypes in families and patients with systemic lupus erythematosus. J Exp Med 159:691-703 10.1084/jem.159.3.691
15. Egger M, Davey SG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634 9310563
16. Egger M, Smith GD, Phillips AN (1997) Meta-analysis: Principles and procedures. BMJ 315:1533-1537 9432252
17. Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga TW (1998) Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci USA 95:9465-9470 10.1073/pnas.95.16.9465
18. Eskdale J, Wordsworth P, Bowman S, Field M, Gallagher G (1997) Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus. Tissue Antigens 49:635-639 9234486
19. Gibson AW, Edberg JC, Wu J, Westendorp RG, Huizinga TW, Kimberly RP (2001) Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 166:3915-3922 11238636
20. Harley JB, Moser KL, Gaffney PM, Behrens TW (1998) The genetics of human systemic lupus erythematosus. Curr Opin Immunol 10:690-696 10.1016/ S0952-7915(98)80090-3
21. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539-1558 10.1002/sim.1186
22. Hirschhorn JN, Altshuler D (2002) Once and again-issues surrounding replication in genetic association studies. J Clin Endocrinol Metab 87: 4438-4441 10.1210/jc.2002-021329
23. Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, Howard M (1994) Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 179 305-310 10.1084/ jem.179.1.305
24. Johanneson B, Lima G, von Salome J, Alarcon-Segovia D, Alarcon-Riquelme ME (2002) A major susceptibility locus for systemic lupus erythematosus maps to chromosome 1q31. Am J Hum Genet 71:1060-1071 12373647
25. Kelly JA, Moser KL, Harley JB (2002) The genetics of systemic lupus erythematosus: Putting the pieces together. Genes Immun 3(Suppl 1):S71-S85 10.1038/sj.gene.6363885
26. Khoa PD, Sugiyama T, Yokochi T (2005) Polymorphism of interleukin-10 promoter and tumor necrosis factor receptor II in Vietnamese patients with systemic lupus erythematosus. Clin Rheumatol 24(1):11-13 10.1007/ s10067-004-0952-1
27. Kiss E, Csipo I, Cohen JH, Reveil B, Kavai M, Szegedi G (1996) CR1 density polymorphism and expression on erythrocytes of patients with systemic lupus erythematosus. Autoimmunity 25:53-58 9161700
28. Kumar A, Kumar A, Sinha S, Khandekar PS, Banerjee K, Srivastava LM (1995) Hind III genomic polymorphism of the C3b receptor (CR1) in patients with SLE: Low erythrocyte CR1 expression is an acquired phenomenon. Immunol Cell Biol 73:457-462 8595925
29. Lazarus M, Hajeer AH, Turner D, Sinnott P, Worthington J, Ollier WE, Hutchinson X (1997) Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol 24:2314-2317 9415634
30. Llorente L, Richaud-Patin Y, Couderc J, Alarcon-Segovia D, Ruiz-Soto R, Alcocer-Castillejos N, Alcocer-Varela J, Granados J, Bahena S, Galanaud P, Emilie D (1997) Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus. Arthritis Rheum 40:1429-1435 9259422
31. Llorente L, Richaud-Patin Y, Garcia-Padilla C, Claret E, Jakez-Ocampo J, Cardiel MH, Alcocer-Varela J, Grangeot-Keros L, Alarcon-Segovia D, Wijdenes J, Galanaud P, Emilie D (2000) Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum 43:1790-1800 10.1002/ 1529-0131(200008)43:8<1790::AID-ANR15>3.0.CO;2-2
32. Mehrian R, Quismorio FP, Jr., Strassmann G, Stimmler MM, Horwitz DA, Kitridou RC, Gauderman WJ, Morrison J, Brautbar C, Jacob CO (1998) Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus. Arthritis Rheum 41:596-602 10.1002/1529-0131(199804)41:4<596::AID-ART6>3.0.CO;2-2
33. Mok CC, Lanchbury JS, Chan DW, Lau CS (1998) Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 41:1090-1095 9627019
34. Moldenhauer F, Botto M, Walport MJ (1988) The rate of loss of CR1 from ageing erythrocytes in vivo in normal subjects and SLE patients: No correlation with structural or numerical polymorphisms. Clin Exp Immunol 72:74-78 2899464
35. Moldenhauer F, David J, Fielder AH, Lachmann PJ, Walport MJ (1987) Inherited deficiency of erythrocyte complement receptor type 1 does not cause susceptibility to systemic lupus erythematosus. Arthritis Rheum 30:961-966 2959289
36. Moore KW, de Waal MR, Coffman RL, O'Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683-765 10.1146/ annurev.immunol.19.1.683
37. Moulds JM, Reveille JD, Arnett FC (1996) Structural polymorphisms of complement receptor 1 (CR1) in systemic lupus erythematosus (SLE) patients and normal controls of three ethnic groups. Clin Exp Immunol 105:302-305 10.1046/j.1365-2249.1996.d01-748.x
38. Nath SK, Kilpatrick J, Harley JB (2004) Genetics of human systemic lupus erythematosus: The emerging picture. Curr Opin Immunol 16:794-800 10.1016/j.coi.2004.09.007
39. Park YB, Lee SK, Kim DS, Lee J, Lee CH, Song CH (1998) Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 16:283-288 9631750
40. Reveille JD, Moulds JM, Ahn C, Friedman AW, Baethge B, Roseman J, et al. (1998) Systemic lupus erythematosus in three ethnic groups: I.The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum 41:1161-1172 10.1002/ 1529-0131(199807)41:7<1161::AID-ART4>3.0.CO;2-K
41. Rood MJ, Keijsers V, van der Linden MW, Tong TQ, Borggreve SE, Verweij CL, Breedveld FC, Huizinga TW (1999) Neuropsychiatric systemic lupus erythematosus is associated with imbalance in interleukin 10 promoter haplotypes. Ann Rheum Dis 58:85-89 10343522
42. Ross GD (1992) Complement receptor type 1. Curr Top Microbiol Immunol 178:31-44 1424775
43. Satoh H, Yokota E, Tokiyama K, Kawaguchi T, Niho Y (1991) Distribution of the HindIII restriction fragment length polymorphism among patients with systemic lupus erythematosus with different concentrations of CR1. Ann Rheum Dis 50:765-768 1685310
44. Schotte H, Gaubitz M, Willeke P, Tidow N, Assmann G, Domschke W, Schluter B (2004) Interleukin-10 promoter microsatellite polymorphisms in systemic lupus erythematosus: Association with the anti-Sm immune response. Rheumatology (Oxford) 43:1357-1363 10.1093/rheumatology/keh353
45. Sullivan KE, Jawad AF, Piliero LM, Kim N, Luan X, Goldman D, Petri M (2003) Analysis of polymorphisms affecting immune complex handling in systemic lupus erythematosus. Rheumatology (Oxford) 42:446-452 10.1093/ rheumatology/keg157
46. Taga K, Tosato G (1992) IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 148:1143-1148 1737931
47. Tebib JG, Martinez C, Granados J, Alarcon-Segovia D, Schur PH (1989) The frequency of complement receptor type 1 (CR1) gene polymorphisms in nine families with multiple cases of systemic lupus erythematosus. Arthritis Rheum 32:1465-1469 2573360
48. Tsao BP, Cantor RM, Grossman JM, Shen N, Teophilov NT, Wallace DJ, Arnett FC, Hartung K, Goldstein R, Kalunian KC, Hahn BH, Rotter JI (1999) PARP alleles within the linked chromosomal region are associated with systemic lupus erythematosus. J Clin Invest 103:1135-1140 10207165
49. van der Linden MW, Westendorp RG, Sturk A, Bergman W, Huizinga TW (2000) High interleukin-10 production in first-degree relatives of patients with generalized but not cutaneous lupus erythematosus. J Investig Med 48:327-334 10979237
50. van Dyne S, Holers VM, Lublin DM, Atkinson JP (1987) The polymorphism of the C3b/C4b receptor in the normal population and in patients with systemic lupus erythematosus. Clin Exp Immunol 68:570-579 2958190
51. Weiss L, Delfraissy JF, Vazquez A, Wallon C, Galanaud P, Kazatchkine MD (1987) Monoclonal antibodies to the human C3b/C4b receptor (CR1) enhance specific B cell differentiation. J Immunol 138:2988-2993 2952731
52. Westendorp RG, Langermans JA, Huizinga TW, Elouali AH, Verweij CL, Boomsma DI, Vandenbroucke JP (1997) Genetic influence on cytokine production and fatal meningococcal disease. Lancet 349:170-173 10.1016/ S0140-6736(96)06413-6
53. Wilson JG, Murphy EE, Wong WW, Klickstein LB, Weis JH, Fearon DT (1986) Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes. J Exp Med 164:50-59 10.1084/jem.164.1.50
54. Wilson JG, Wong WW, Murphy EE III, Schur PH, Fearon DT (1987) Deficiency of the C3b/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: Analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR1 gene. J Immunol 138:2708-2710 2881967
55. Wong WW, Cahill JM, Rosen MD, Kennedy CA, Bonaccio ET, Morris MJ, Wilson JG, Klickstein LB, Fearon DT (1989) Structure of the human CR1 gene. Molecular basis of the structural and quantitative polymorphisms and identification of a new CR1-like allele. J Exp Med 169:847-863 10.1084/ jem.169.3.847
56. Wong WW, Wilson JG, Fearon DT (1983) Genetic regulation of a structural polymorphism of human C3b receptor. J Clin Invest 72:685-693 6223944
57. Yusuf S, Peto R, Lewis J, Collins R, Sleight P (1985) Beta blockade during and after myocardial infarction: An overview of the randomized trials. Prog Cardiovasc Dis 27:335-371 2858114